A Phase 2 Study of durcabtagene autoleucel, B-cell Maturation Antigen (BCMA) - directed CAR-T Cells in adult participants with relapsed and refractory multiple myeloma

  • Spencer, Andrew (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date18/02/22 → 31/12/27

Keywords

  • Malignant Haematology
  • Multiple myeloma
  • Clinical trial